Boston Scientific announces conference call discussing second quarter 2025 results
Boston Scientific (NYSE:BSX) has scheduled a conference call to discuss its second quarter 2025 financial results and business highlights. The call will take place on July 23, 2025, at 8:00 a.m. ET, featuring Chairman and CEO Mike Mahoney and CFO Jon Monson.
The company will release its Q2 2025 financial results prior to the conference call. Investors can access both the live webcast and replay through the company's investor relations website, with the replay becoming available approximately one hour after the event concludes.
Boston Scientific (NYSE:BSX) ha programmato una conference call per discutere i risultati finanziari e i principali eventi del secondo trimestre 2025. La chiamata si terrà il 23 luglio 2025 alle 8:00 AM ET, con la partecipazione del Presidente e CEO Mike Mahoney e del CFO Jon Monson.
L'azienda pubblicherà i risultati finanziari del secondo trimestre 2025 prima della conference call. Gli investitori potranno seguire sia la diretta web che la registrazione tramite il sito web delle relazioni con gli investitori della società; la registrazione sarà disponibile circa un'ora dopo la conclusione dell'evento.
Boston Scientific (NYSE:BSX) ha programado una llamada de conferencia para discutir sus resultados financieros y aspectos destacados del segundo trimestre de 2025. La llamada tendrá lugar el 23 de julio de 2025 a las 8:00 a.m. ET, con la participación del presidente y CEO Mike Mahoney y el CFO Jon Monson.
La compañía publicará sus resultados financieros del segundo trimestre de 2025 antes de la llamada. Los inversores podrán acceder tanto a la transmisión en vivo como a la repetición a través del sitio web de relaciones con inversores de la empresa, con la repetición disponible aproximadamente una hora después de que finalice el evento.
Boston Scientific (NYSE:BSX)는 2025년 2분기 재무 실적 및 주요 사업 내용을 논의하기 위한 컨퍼런스 콜을 예정했습니다. 콜은 2025년 7월 23일 오전 8시 ET에 진행되며, 회장 겸 CEO 마이크 매호니와 CFO 존 몬슨이 참석합니다.
회사는 컨퍼런스 콜 전에 2025년 2분기 재무 실적을 발표할 예정입니다. 투자자는 회사 투자자 관계 웹사이트를 통해 생중계 및 녹화 방송에 접속할 수 있으며, 녹화 방송은 행사 종료 약 1시간 후에 제공됩니다.
Boston Scientific (NYSE:BSX) a programmé une conférence téléphonique pour discuter des résultats financiers et des faits marquants du deuxième trimestre 2025. L'appel aura lieu le 23 juillet 2025 à 8h00 ET, avec la participation du président-directeur général Mike Mahoney et du directeur financier Jon Monson.
La société publiera ses résultats financiers du deuxième trimestre 2025 avant la conférence téléphonique. Les investisseurs pourront accéder à la diffusion en direct ainsi qu'à la rediffusion via le site web des relations investisseurs de l'entreprise, la rediffusion étant disponible environ une heure après la fin de l'événement.
Boston Scientific (NYSE:BSX) hat eine Telefonkonferenz zur Besprechung der Finanzergebnisse und Geschäftshighlights des zweiten Quartals 2025 angesetzt. Die Konferenz findet am 23. Juli 2025 um 8:00 Uhr ET statt, mit dem Vorsitzenden und CEO Mike Mahoney sowie dem CFO Jon Monson.
Das Unternehmen wird die Finanzergebnisse für das 2. Quartal 2025 vor der Telefonkonferenz veröffentlichen. Investoren können sowohl den Live-Webcast als auch die Aufzeichnung über die Investor-Relations-Website des Unternehmens verfolgen; die Aufzeichnung wird etwa eine Stunde nach Ende der Veranstaltung verfügbar sein.
- None.
- None.
A live webcast and replay for the event will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-second-quarter-2025-results-302495273.html
SOURCE Boston Scientific Corporation
FAQ
When is Boston Scientific (BSX) reporting Q2 2025 earnings?
Who will host Boston Scientific's Q2 2025 earnings call?
How can investors access Boston Scientific's Q2 2025 earnings call?
When will the replay of BSX's Q2 2025 earnings call be available?
